Company Filing History:
Years Active: 1996
Title: Seiji Nakane: Innovator in Microbial Biotechnology
Introduction
Seiji Nakane is a prominent inventor based in Aichi, Japan. He has made significant contributions to the field of microbial biotechnology, particularly in the area of caffeine metabolism. His innovative work has led to advancements in the production of valuable compounds through microbial processes.
Latest Patents
Seiji Nakane holds a patent for a "Caffeine demethylate gene-containing DNA fragment and microbial process." This patent describes a DNA fragment containing a caffeine demethylase gene produced by a microorganism belonging to the genus Pseudomonas. The process involves cultivating a novel bacterium strain of the genus Pseudomonas that has been transformed with recombinant DNA. This strain is capable of assimilating caffeine and producing 3-methyl-7-alkylxanthine, which can be recovered from the culture.
Career Highlights
Throughout his career, Seiji Nakane has been associated with Amano Pharmaceutical Co., Ltd. His work has focused on utilizing microbial processes to convert caffeine and related compounds into useful products. His innovative approaches have contributed to the advancement of biotechnology in pharmaceutical applications.
Collaborations
Seiji Nakane has collaborated with notable colleagues, including Yoshinao Koide and Yutaka Imai. These collaborations have fostered a productive environment for research and development in microbial biotechnology.
Conclusion
Seiji Nakane's contributions to microbial biotechnology, particularly through his patented processes, highlight his role as an innovator in the field. His work continues to influence the production of valuable compounds from caffeine, showcasing the potential of microbial processes in biotechnology.